Last Update: February 13, 2026
The featured pick this month is Indo US Bio-Tech. This strong agri-biotech company is growing and becoming more cost-effective. The company's median sales growth has been 20.2% over the past decade, and its profits have grown at 45% CAGR over the past five. This means the company will last. The decrease in debtor days, from 98.9 to 52.7 days, indicates that the company has improved its operational efficiency. This sign indicates better cash flow management. The stock's 18.0 P/E is lower than the industry average of 24.5, so it appears to be priced fairly. The promoters' 70.2% stake shows their confidence in the company's future.
![]() |
| INDOUS / Daily Chart |
Elliott Wave Theory supports this analysis by suggesting a long-term Wave 3. A bullish cycle's peak is usually here. If this wave structure holds, the stock could rise quickly. However, this bullish outlook would end if the market price falls below its all-time low. Such an outcome would indicate that the wave count was wrong and that the trend needed reevaluation.
Disclaimer
This post is just for informative purposes and does not constitute financial advice. Trading and investing involve risk, and past performance does not guarantee future results. Before making an investing or trading choice, readers should undertake their own research and evaluate their own circumstances. The author and platform accept no responsibility for any financial losses or damages stemming from the use of this material. Receive personalized advice from a qualified financial advisor.
Update: January 07, 2026
![]() |
| TMB / Hourly Chart |
Stock Update For 07 May'25
BHARTI AIRTEL LTD
![]() |
BHARTI AIRTEL LTD / 3 Min |
Disclaimer
This post is just for informative purposes and does not constitute financial advice. Trading and investing involve risk, and past performance does not guarantee future results. Before making an investing or trading choice, readers should undertake their own research and evaluate their own circumstances. The author and platform accept no responsibility for any financial losses or damages stemming from the use of this material. Receive personalized advice from a qualified financial advisor.



No comments:
Post a Comment